More about
Common Serious Adverse Vomiting
News
October 18, 2024
1 min read
Save
FDA approves Vyloy with chemotherapy for some gastric cancers, approves diagnostic device
The FDA approved Vyloy with chemotherapy to treat locally advanced unresectable or metastatic HER2-negative gastric or gastroesophageal junction adenocarcinoma in adults, according to a press release.